Phase I/II randomised, double-blind, placebo-controlled trial of trabodenoson [INO 8875] in patients with primary open-angle glaucoma or ocular hypertension
Latest Information Update: 08 Oct 2013
At a glance
- Drugs Trabodenoson (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Inotek Pharmaceuticals
- 08 Oct 2013 New trial record